Organogenesis Holdings (ORGO) Debt to Equity (2017 - 2024)
Historic Debt to Equity for Organogenesis Holdings (ORGO) over the last 8 years, with Q3 2024 value amounting to $0.22.
- Organogenesis Holdings' Debt to Equity fell 866.58% to $0.22 in Q3 2024 from the same period last year, while for Sep 2024 it was $0.22, marking a year-over-year decrease of 866.58%. This contributed to the annual value of $0.24 for FY2023, which is 1077.64% down from last year.
- Latest data reveals that Organogenesis Holdings reported Debt to Equity of $0.22 as of Q3 2024, which was down 866.58% from $0.24 recorded in Q2 2024.
- In the past 5 years, Organogenesis Holdings' Debt to Equity ranged from a high of $1.67 in Q2 2020 and a low of $0.22 during Q3 2024
- Its 5-year average for Debt to Equity is $0.47, with a median of $0.29 in 2022.
- In the last 5 years, Organogenesis Holdings' Debt to Equity soared by 785.07% in 2020 and then tumbled by 7996.26% in 2021.
- Quarter analysis of 5 years shows Organogenesis Holdings' Debt to Equity stood at $0.54 in 2020, then plummeted by 43.72% to $0.3 in 2021, then decreased by 12.45% to $0.27 in 2022, then decreased by 10.78% to $0.24 in 2023, then decreased by 6.17% to $0.22 in 2024.
- Its last three reported values are $0.22 in Q3 2024, $0.24 for Q2 2024, and $0.23 during Q1 2024.